Fate Therapeutics Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to be Featured at 2018 AACR Annual Meeting Press Program

World News: . []

SAN DIEGO April 16 2018 GLOBE NEWSWIRE -- Fate Therapeutics Inc NASDAQFATE a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders announced today th at the ...

More news and information about Fate Therapeutics, Inc.

Published By:

Globe Newswire: 14:30 GMT Monday 16th April 2018

Published: .

Search for other references to "fate" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us